Taft attorney Stephen Auten will present at the Biosimilar Summit 2015, which will take place Sept. 9-11, 2015, in Washington, D.C. Auten’s presentation is titled “Breaking Down the ‘Patent Dance’ Process.”

Auten is head of Taft's Pharmaceutical and Life Sciences Litigation practice. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog "Hatch Waxman ANDA Litigation Forum," which has nearly 6,000 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation and biosimilar market opportunities.